Stock Track | iRhythm Technologies Soars 7.02% Intraday After Q1 Revenue Tops Estimates

Stock Track04:09

iRhythm Technologies Inc. (IRTC) saw its stock price soar 7.02% during intraday trading on Thursday, following the release of its first-quarter financial results.

The medical technology company reported Q1 2026 revenue of $199.4 million, surpassing the IBES estimate of $194 million. This positive earnings surprise appears to be the primary driver behind the significant share price increase.

Additionally, the company reported a strong gross margin of 70.9% and a gross profit of $141.4 million for the quarter. While iRhythm Technologies reported a net loss for the period, the better-than-expected top-line performance has fueled investor optimism.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment